Flora Inc.
Flora Inc. develops “Flora AI” using ChatGPT for FemTech
Flora Co., Ltd. has developed a chat assistant function “Flora AI” that specializes in women’s health issues using ChatGPT.
[Image
, etc., and propose the optimal solution according to the user's situation.
Benefits of Flora AI
There is already a FemTech service that allows you to chat with experts, etc. There are three advantages to choosing Flora AI: 1. Speedy, 2. Reasonable, and 3. Comprehensive.
1. Speedy
Since AI handles everything, you can get an answer immediately 24 hours a day. 2. Reasonable
Since the operating cost is lower than that of human chat
consultation, we offer it at a reasonable price.
3. Comprehensive
By linking with other functions of the company, it is possible to deal with issues that cannot be solved by chat alone.
We provide one-stop support from enlightenment via chat to access to solutions. the next deployment
Flora AI is scheduled to be implemented after May 2023 and will be released for a fee. However, since the beta version has already been well received, it is assumed that the number of devices that can be used will be limited to prevent intensive access.
Users who have registered on the waiting list will be given priority, so please feel free to register using the form below.
In addition to personal information, all information entered by users is strictly managed and protected, and in accordance with Flora's personal information protection policy, we provide an environment where you can consult with peace of mind.
waiting list
Waiting list registration form
<a href=)
https://forms.gle/QmSJN77CuwQP1bhv8If you register your email address in the form above, you will receive an invitation email to scale up the service.
Outline of Flora Co., Ltd.
Company name: Flora Co., Ltd.
Location: 32 Yoshida Tachibanacho, Sakyo Ward, Kyoto City
Representative: Anna Kreshenko
Established: December 2020
Email: admin@floramaternity.com
URL: https://www.flora-tech.jp/
Details about this release:
https://prtimes.jp/main/html/rd/p/000000021.000072971.html
MAIL:cr@prtimes.co.jp